Prognosis in Advanced Cancer - Softcover

Dr. Paul Glare has been a Fellow of the Royal Australian College of Physicians since 1990, a Fellow of the Chapter of Palliative Medicine since it was created in 2000 and is a Fellow of the Faculty of Pain Medicine. As well as maintaining a full clinical load, he is an active teacher and researcher. His principal research interests are prognostication and the anorexia cachexia syndrome. He was the inaugural Research Fellow in the Palliative Care Program at the Cleveland Clinic Foundation, Ohio USA, from 1989 until 1991. For more than 15 years he has taken a leadership role in the development of the specialty of palliative medicine, both locally and internationally, and is currently managing major initiatives in palliative care education and service delivery for the New South Wales Department of Health. Nicholas Christakis is an internist and social scientist who conducts research on social factors that affect health, health care, and longevity. His clinical work is in the field of palliative medicine. Dr. Christakis's past research has examined the accuracy and role of prognosis in medicine, ways of improving end of life care, and the determinants and outcomes of hospice use. He is currently concerned with health and social networks, and specifically with how ill health disability, health behavior, health care, and death in one person can influence the same phenomena in others in a person's social network, including issues related to caregiver burden. Dr. Christakis was the recipient of the Distinguished Researcher Award, National National Hospice and Palliative Care Organization, awarded for an "outstanding body of work contributing to the enhancement of hospice and palliative care" in 2006.

"Paul Glare and Nicholas A. Christakis, leaders in the field of prognosis, bring together a tem of international contributors from across the fields of palliative care and oncology.... This book is essential reading for anyone involved in predicting the course of advanced cancer, and who needs to ensure that the chances of a "good death" are maximized."--Anticancer Research